Medical Equipment

Neuromodulation Market Forecast 2026–2030 Highlighting Expansion Across Industries

April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Neuromodulation Market During 2026–2030?

The size of the neuromodulation market has experienced rapid growth over recent years. This market is forecast to increase from $7.62 billion in 2025 to $8.45 billion in 2026, driven by a compound annual growth rate (CAGR) of 10.9%. During the historic period, this expansion was driven by several factors, including the increasing prevalence of chronic pain conditions, a rise in neurological disorder incidence, broader acceptance of minimally invasive therapies, the establishment of more specialized pain management centers, and the development of advanced implantable devices.

The neuromodulation market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $12.88 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.1%. This projected growth can be attributed to several factors including the increasing embrace of AI-assisted neuromodulation systems, a rising demand for home-based neuromodulation therapies, the broadening of indications for psychiatric and neurological disorders, an intensifying focus on patient-specific stimulation protocols, and ongoing technological progress in biomaterials and device miniaturization. Significant trends expected during this forecast period involve the increasing adoption of implantable neuromodulation devices, a rise in the use of non-invasive neuromodulation therapies, the growing integration of smart and programmable stimulators, the expansion of neuromodulation applications beyond pain management, and an enhanced emphasis on personalized neurotherapy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

What Leading Drivers Are Supporting The Neuromodulation Market Expansion?

The neuromodulation market is projected to expand due to increasing healthcare expenditures. Healthcare expenditure refers to the total money allocated to health care and associated activities, encompassing the provision of health services, private and public health insurance, health research, and public health efforts. Rising expenditures foster the development and integration of new therapies and diagnostic approaches for neurological disorders. Additionally, increased funding enables more extensive research into novel neuromodulation technologies, thereby enhancing their efficacy, safety, and targeting capabilities. For instance, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure increased by 5.6% in nominal terms in 2023, marking a 0.9% growth compared to 2022. Thus, growing healthcare expenditure is propelling the growth of the neuromodulation market.

Which Segment Types Are Examined In The Neuromodulation Market Segment Study?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

What Emerging Trends Are Seen In The Neuromodulation Market?

Leading companies in the neuromodulation market are concentrating on developing advanced next-generation devices, such as sophisticated implantable pulse generators (IPGs), with the goal of enhancing therapeutic precision, improving patient comfort, and sustaining a competitive advantage. An IPG is a compact, battery-powered unit typically implanted under the skin, often in the chest or abdomen, which delivers targeted electrical stimulation to manage neurological disorders. These advancements aim to offer greater customization, better battery performance, and simplified implantation procedures. For instance, in July 2023, Boston Scientific Corporation, a US-based biotechnology and biomedical engineering firm, obtained FDA approval for its Vercise Neural Navigator 5 software with STIMVIEW XT technology, designed for integration with the fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. The platform features both rechargeable and non-rechargeable IPGs and supports five MR-Conditional implantable pulse generators (IPGs), providing the most extensive therapy options to personalize DBS therapy for individuals with Parkinson’s disease or essential tremor.

Which Players Are Part Of The Competitive Landscape Of The Neuromodulation Market?

Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation

Get The Full Neuromodulation Market Report:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Which Region Leads The Neuromodulation Market In Terms Of Market Share?

North America was the largest region in the neuromodulation market in 2025. The regions covered in the neuromodulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Neuromodulation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Browse Through More Reports Similar to the Global Neuromodulation Market 2026, By The Business Research Company

Nephrologists Market Report 2020 2030 Covid 19 Implications And Growth 2026

https://www.thebusinessresearchcompany.com/report/nephrologists-market-global-report-2020-2030-covid-19-implications-and-growth

Neurology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Brain Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795